Tech Times of New York
SEE OTHER BRANDS

Hottest science and technology news from New York

Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on July 30, 2025

Dragonfly Energy Announces Pricing of $5.5 Million Public Offering of Common Stock

Dragonfly Energy Announces Pricing of $5.5 Million Public Offering of Common Stock

RENO, Nev., July 30, 2025 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), an industry leader in energy storage and battery technology, today announced the pricing of an underwritten public offering …

Acorn, Provider of Remote Monitoring and Control Solutions for Backup Power Generators, Hosts Q2 Earnings Call on Thur. August 7th at 11am ET

Acorn, Provider of Remote Monitoring and Control Solutions for Backup Power Generators, Hosts Q2 Earnings Call on Thur. August 7th at 11am ET

WILMINGTON, Del., July 30, 2025 (GLOBE NEWSWIRE) -- Acorn Energy, Inc. (Nasdaq: ACFN), a provider of remote monitoring and control solutions for backup power generators, gas pipelines and other industrial equipment, will report its second quarter results …

Enlight Expands Its Executive Leadership Team

Enlight Expands Its Executive Leadership Team

Gilad Yavetz, founder of Enlight, to serve as Executive chairman of the board Adi Leviatan to be appointed CEO, bringing a proven track record of executive leadership from leading global companies; Yair Seroussi to serve as vice chairman This step, …

PMGC Holdings Inc. Terminates LOI to Focus on Acquiring High-Growth CNC Precision Manufacturing Companies Serving Aerospace, Defense, and Industrial Markets

PMGC Holdings Inc. Terminates LOI to Focus on Acquiring High-Growth CNC Precision Manufacturing Companies Serving Aerospace, Defense, and Industrial Markets

NEWPORT BEACH, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (Nasdaq: ELAB) (the “Company”, “PMGC” or ”we”), a diversified public holding company, today announced that it has terminated the previously announced non-binding letter of intent, …

BriaCell Awarded New Zealand Patent for its Whole Cell Technology

BriaCell Awarded New Zealand Patent for its Whole Cell Technology

PHILADELPHIA and VANCOUVER, British Columbia, July 30, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to …

Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025

Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025

BOSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, announced today that clinical data …

Creative Realities, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call Information

Creative Realities, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call Information

LOUISVILLE, K.Y., July 30, 2025 (GLOBE NEWSWIRE) -- Creative Realities, Inc. ("Creative Realities," "CRI," or the "Company") (NASDAQ: CREX), a leading provider of digital signage and media solutions, announced today that it will release its financial …

First National Corporation Reports Record Second Quarter 2025 Earnings

First National Corporation Reports Record Second Quarter 2025 Earnings

STRASBURG, Va., July 30, 2025 (GLOBE NEWSWIRE) -- First National Corporation (the “Company” or “First National”) (NASDAQ: FXNC), the bank holding company of First Bank (the “Bank”), reported earnings for the quarter ended June 30, 2025 of $5.05 million and …

Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products

Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products

DURHAM, N.C., July 30, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, announced today a significant milestone with the U.S. Food and Drug Administration (FDA) 510(k) clearances for both TalisMann™ …

TG Therapeutics to Host Conference Call on Second Quarter 2025 Financial Results and Business Update

TG Therapeutics to Host Conference Call on Second Quarter 2025 Financial Results and Business Update

NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Monday, August 4, 2025, at 8:30 AM ET to discuss results for the second quarter of 2025 and provide a business outlook …

NextGen Digital Platforms Announces Plans to Expand AI Strategy through Integration with Bittensor Network

NextGen Digital Platforms Announces Plans to Expand AI Strategy through Integration with Bittensor Network

Vancouver, BC, July 30, 2025 (GLOBE NEWSWIRE) -- NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company”) is pleased to announce its planned strategic integration with the Bittensor (TAO) ecosystem, a decentralized …

Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update

Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update

WVE-006, the leading GalNAc-RNA editing oligonucleotide designed to correct AAT protein and address both lung and liver manifestations of AATD, rapidly advancing in RestorAATion-2 study of AATD patients; multi-dosing is complete in first cohort (200 mg) …

Humanoid Global Appoints Dr. Yue Hu to Humanoid Technical Advisory Committee

Humanoid Global Appoints Dr. Yue Hu to Humanoid Technical Advisory Committee

Vancouver, BC, July 30, 2025 (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCPK:RBOHF), a publicly traded investment issuer focused on the humanoid robotics and embodied AI sector,  is pleased …

Appendix 4C – Q4 FY25 Quarterly Cash Flow Report

Appendix 4C – Q4 FY25 Quarterly Cash Flow Report

Highlights Granted U.S. FDA Fast Track Designation for ATH434 to treat Multiple System Atrophy (MSA) Reported positive topline data from open-label Phase 2 clinical trial of ATH434 in MSA Presented additional analyses from the ATH434-201 trial …

Fortune 50 Telecommunication Company Purchases Multiple Draganfly Heavy Lift Drone Systems for Emergency Response and Disaster Recovery Infrastructure Support

Fortune 50 Telecommunication Company Purchases Multiple Draganfly Heavy Lift Drone Systems for Emergency Response and Disaster Recovery Infrastructure Support

Tampa Bay, Florida, July 30, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning developer of drone solutions and systems, and Infinity Communications, a premier provider of rapid …

Verisk Reports Second-Quarter 2025 Financial Results

Verisk Reports Second-Quarter 2025 Financial Results

Second quarter revenue of $773 million, up 7.8%, and up 7.9% on an organic constant currency (OCC) basis. Net income of $253 million, down 17.7% due to gains recognized in the prior year. Adjusted EBITDA, a non-GAAP measure, of $445 million, up 11.9%, and …

Anika Reports Second Quarter 2025 Financial Results

Anika Reports Second Quarter 2025 Financial Results

Regenerative Solutions revenue up 41% with Integrity™ Implant System ahead of expectations and continued strong Hyalofast® growth; Integrity surpasses full year 2024 performance and is on pace to more than double in 2025 Company released topline results …

Pancreatic Cancer Phase 2a Study with Can-Fite’s Namodenoson Achieved Over 50% Enrollment Milestone

Pancreatic Cancer Phase 2a Study with Can-Fite’s Namodenoson Achieved Over 50% Enrollment Milestone

Primary endpoint is safety; Namodenoson continues to demonstrate a favorable safety profile Ramat Gan, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a …

Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast® Cartilage Repair Scaffold and Provides Program Update

Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast® Cartilage Repair Scaffold and Provides Program Update

Hyalofast consistently demonstrated improvements over microfracture, but missed on statistical significance of the pre-specified co-primary endpoints of percent change in KOOS Pain and IKDC function Hyalofast showed statistically significant improvements …

Avacta to Present New FAP Dox (AVA6000) Data at the European Society for Medical Oncology (ESMO) Congress

Avacta to Present New FAP Dox (AVA6000) Data at the European Society for Medical Oncology (ESMO) Congress

LONDON and PHILADELPHIA, July 30, 2025 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, ‘the Company’), a life sciences company developing innovative, targeted oncology drugs, today announces that the Company will present an updated data analysis from …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions